Updated On: 31 December, 2020 12:00 AM IST | New Delhi | ANI
Meanwhile, the Pune-based Serum Institute of India has sought emergency approval for the vaccine--Covishield-- developed along with global pharma giant AstraZeneca and Oxford University

Representational Image | File Pic
Terming the approval for Oxford-AstraZeneca vaccine for use in the UK as a "big step forward", AIIMS Delhi Director Dr Randeep Guleria on Wednesday said that India will have the COVID-19 vaccine within days.
"This is very good news that AstraZeneca got approval for its vaccine by UK regulatory authorities. They have robust data and in India and the same vaccine is being developed by the Serum Institute of India. This is a big step forward not only for India but many parts of the world," Guleria told ANI in an interview.